Shares

20 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 06, 2024

SELL
$0.53 - $0.93 $45,914 - $80,567
-86,632 Reduced 43.59%
112,103 $65,000
Q4 2023

Jan 12, 2024

BUY
$0.63 - $1.14 $105,220 - $190,399
167,017 Added 526.57%
198,735 $165,000
Q3 2023

Oct 13, 2023

BUY
$1.12 - $1.88 $35,524 - $59,629
31,718 New
31,718 $36,000
Q1 2023

Apr 28, 2023

BUY
$1.45 - $2.95 $250,686 - $510,016
172,887 Added 756.12%
195,752 $298,000
Q4 2022

Feb 02, 2023

SELL
$2.02 - $3.25 $72,732 - $117,019
-36,006 Reduced 61.16%
22,865 $55,000
Q3 2022

Oct 31, 2022

SELL
$1.96 - $3.14 $265,286 - $424,999
-135,350 Reduced 69.69%
58,871 $121,000
Q2 2022

Jul 29, 2022

BUY
$1.3 - $2.64 $146,612 - $297,736
112,779 Added 138.48%
194,221 $377,000
Q1 2022

Apr 29, 2022

BUY
$2.35 - $3.47 $79,650 - $117,612
33,894 Added 71.28%
81,442 $200,000
Q4 2021

Feb 07, 2022

SELL
$2.92 - $5.74 $144,431 - $283,917
-49,463 Reduced 50.99%
47,548 $153,000
Q3 2021

Nov 01, 2021

BUY
$4.98 - $6.63 $432,333 - $575,576
86,814 Added 851.37%
97,011 $509,000
Q2 2021

Aug 12, 2021

SELL
$2.56 - $5.49 $63,237 - $135,613
-24,702 Reduced 70.78%
10,197 $56,000
Q1 2021

May 13, 2021

BUY
$2.69 - $5.25 $52,565 - $102,590
19,541 Added 127.24%
34,899 $95,000
Q4 2020

Feb 04, 2021

SELL
$3.17 - $4.49 $48,418 - $68,580
-15,274 Reduced 49.86%
15,358 $49,000
Q3 2020

Nov 09, 2020

BUY
$2.98 - $5.2 $8,007 - $13,972
2,687 Added 9.62%
30,632 $123,000
Q2 2020

Jul 20, 2020

BUY
$2.29 - $4.24 $4,593 - $8,505
2,006 Added 7.73%
27,945 $110,000
Q1 2020

Apr 30, 2020

BUY
$1.92 - $4.39 $21,448 - $49,040
11,171 Added 75.64%
25,939 $64,000
Q4 2019

Jan 28, 2020

BUY
$2.41 - $4.4 $35,590 - $64,979
14,768 New
14,768 $60,000
Q2 2018

Aug 07, 2018

SELL
$2.26 - $4.65 $35,597 - $73,242
-15,751 Closed
0 $0
Q1 2018

May 03, 2018

BUY
$3.51 - $6.04 $19,827 - $34,119
5,649 Added 55.92%
15,751 $74,000
Q4 2017

Jan 24, 2018

BUY
$3.26 - $4.78 $32,932 - $48,287
10,102
10,102 $33,000

Others Institutions Holding AGEN

About AGENUS INC


  • Ticker AGEN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 283,163,008
  • Market Cap $4.73B
  • Description
  • Agenus Inc., a clinical-stage immuno-oncology company, discovers and develops immuno-oncology products in the United States and internationally. The company offers Retrocyte Display, an antibody expression platform for the identification of fully human and humanized monoclonal antibodies; and display technologies. It develops vaccine programs co...
More about AGEN
Track This Portfolio

Track Sg Americas Securities, LLC Portfolio

Follow Sg Americas Securities, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Sg Americas Securities, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Sg Americas Securities, LLC with notifications on news.